A Vaccine Against Group B Streptococcus: Recent Advances C Carreras-Abad, L Ramkhelawon, PT Heath, K Le Doare Infection and drug resistance, 1263-1272, 2020 | 116 | 2020 |
Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates F Bianchi-Jassir, P Paul, KN To, C Carreras-Abad, AC Seale, ... Vaccine 38 (43), 6682-6694, 2020 | 104 | 2020 |
Post COVID-19 condition in children and adolescents: an emerging problem J Izquierdo-Pujol, S Moron-Lopez, J Dalmau, A Gonzalez-Aumatell, ... Frontiers in pediatrics 10, 894204, 2022 | 73 | 2022 |
Group B Streptococcus: trials and tribulations HG Davies, C Carreras-Abad, K Le Doare, PT Heath The Pediatric Infectious Disease Journal 38 (6S), S72-S76, 2019 | 41 | 2019 |
Multisystem inflammatory syndrome in children and SARS-CoV-2 variants: a two-year ambispective multicentric cohort study in Catalonia, Spain R Pino, JM Antoñanzas, F Paredes-Carmona, A Perramon, JG Rivière, ... European journal of pediatrics 182 (4), 1897-1909, 2023 | 21 | 2023 |
Social, academic and health status impact of long COVID on children and young people: An observational, descriptive, and longitudinal cohort study A Gonzalez-Aumatell, MV Bovo, C Carreras-Abad, S Cuso-Perez, ... Children 9 (11), 1677, 2022 | 21 | 2022 |
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial B Grau-Pujol, D Camprubí-Ferrer, H Marti-Soler, M Fernández-Pardos, ... Trials 22, 1-10, 2021 | 18 | 2021 |
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: initial results of a double-blind, placebo-controlled randomized clinical trial B Grau-Pujol, D Camprubí, H Marti-Soler, M Fernández-Pardos, ... | 14 | 2021 |
Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study C Carreras-Abad, M Cochet, T Hall, L Ramkhelawon, A Khalil, ... Health Technology Assessment (Winchester, England) 23 (67), 1, 2019 | 11 | 2019 |
Detection of group B streptococcus colonisation in pregnant women: Comparison of two different culture methods and study of antimicrobial resistance patterns. C Carreras-Abad, KN To, L Ramkhelawon, T Planche, I Monahan, ... | 7 | 2021 |
Health and vaccination status of unaccompanied minors after arrival in a European border country: a cross-sectional study (2017–2020) C Carreras-Abad, I Oliveira-Souto, D Pou-Ciruelo, JM Pujol-Morro, ... The Pediatric Infectious Disease Journal 41 (11), 872-877, 2022 | 5 | 2022 |
Integrase inhibitors in children and adolescents: clinical use and resistance D Torres-Fernandez, S Jiménez de Ory, C Fortuny, T Sainz, D Falcón, ... Journal of Antimicrobial Chemotherapy 77 (10), 2784-2792, 2022 | 5 | 2022 |
A vaccine against group B streptococcus: recent advances. Infect Drug Resist 13: 1263–1272 C Carreras-Abad, L Ramkhelawon, PT Heath, K Le Doare | 5 | 2020 |
A vaccine against group B Streptococcus: recent advances. Infect Drug Resist. 2020; 13: 1263–72 C Carreras-Abad, L Ramkhelawon, PT Heath, K Le Doare Epub 2020/05/20. doi: 10.2147/IDR, 0 | 5 | |
Results of the REIV-TOXO national survey on prenatal screening for toxoplasmosis in Spain B Guarch-Ibáñez, C Carreras-Abad, MA Frick, D Blázquez-Gamero, ... Enfermedades infecciosas y microbiologia clinica (English ed.) 42 (9), 478-483, 2024 | 3 | 2024 |
Factors associated with late presentation for HIV care in adolescents in Spain C Epalza, S Domínguez‐Rodríguez, E Cervantes, S Jiménez de Ory, ... HIV medicine 23 (11), 1195-1201, 2022 | 2 | 2022 |
Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens C Carreras-Abad, M Espiau, L López-Seguer, N Martín-Begué, ... Archivos de bronconeumologia 56 (12), 823-825, 2020 | 2 | 2020 |
Resultados de la encuesta nacional de REIV-TOXO sobre el cribado gestacional de la toxoplasmosis en España B Guarch-Ibáñez, C Carreras-Abad, MA Frick, D Blázquez-Gamero, ... Enfermedades Infecciosas y Microbiología Clínica 42 (9), 478-483, 2024 | 1 | 2024 |
REIV-TOXO Project: Results from a Spanish cohort of congenital toxoplasmosis (2015–2022). The beneficial effects of prenatal treatment on clinical outcomes of infected newborns B Guarch-Ibáñez, C Carreras-Abad, MA Frick, D Blázquez-Gamero, ... PLoS neglected tropical diseases 18 (10), e0012619, 2024 | | 2024 |
Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID SD Tyrkalska, F Pérez-Sanz, L Franco-Martínez, CP Rubio, ... Frontiers in cellular and infection microbiology 14, 1396263, 2024 | | 2024 |